A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

However, the findings also show decreases in opioid outcomes after medical ... Researchers 'See' Vulnerability to Gaming Addiction in the Adolescent Brain Dec. 9, 2024 — Researchers found ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...